These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32487486)

  • 1. Genomic Instability in Multiple Myeloma.
    Alagpulinsa DA; Szalat RE; Poznansky MC; Shmookler Reis RJ
    Trends Cancer; 2020 Oct; 6(10):858-873. PubMed ID: 32487486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic instability in multiple myeloma: mechanisms and therapeutic implications.
    Neri P; Bahlis NJ
    Expert Opin Biol Ther; 2013 Jun; 13 Suppl 1():S69-82. PubMed ID: 23782016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome instability in multiple myeloma.
    Neuse CJ; Lomas OC; Schliemann C; Shen YJ; Manier S; Bustoros M; Ghobrial IM
    Leukemia; 2020 Nov; 34(11):2887-2897. PubMed ID: 32651540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of DNA Repair in Genomic Instability of Multiple Myeloma.
    Ali JYH; Fitieh AM; Ismail IH
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms and Clinical Applications of Genome Instability in Multiple Myeloma.
    Cagnetta A; Lovera D; Grasso R; Colombo N; Canepa L; Ballerini F; Calvio M; Miglino M; Gobbi M; Lemoli R; Cea M
    Biomed Res Int; 2015; 2015():943096. PubMed ID: 26579543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic Instability in Multiple Myeloma: A "Non-Coding RNA" Perspective.
    Taiana E; Gallo Cantafio ME; Favasuli VK; Bandini C; Viglietto G; Piva R; Neri A; Amodio N
    Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33924959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decoupling of normal CD40/interleukin-4 immunoglobulin heavy chain switch signal leads to genomic instability in SGH-MM5 and RPMI 8226 multiple myeloma cell lines.
    Hwang WY; Gullo CA; Shen J; Poh CK; Tham SC; Cow G; Au M; Chan EW; Teoh G
    Leukemia; 2006 Apr; 20(4):715-23. PubMed ID: 16453006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA repair pathways in human multiple myeloma: role in oncogenesis and potential targets for treatment.
    Gourzones-Dmitriev C; Kassambara A; Sahota S; Rème T; Moreaux J; Bourquard P; Hose D; Pasero P; Constantinou A; Klein B
    Cell Cycle; 2013 Sep; 12(17):2760-73. PubMed ID: 23966156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of Genomic Instability in Breast Cancer.
    Duijf PHG; Nanayakkara D; Nones K; Srihari S; Kalimutho M; Khanna KK
    Trends Mol Med; 2019 Jul; 25(7):595-611. PubMed ID: 31078431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From MGUS to Multiple Myeloma, a Paradigm for Clonal Evolution of Premalignant Cells.
    van Nieuwenhuijzen N; Spaan I; Raymakers R; Peperzak V
    Cancer Res; 2018 May; 78(10):2449-2456. PubMed ID: 29703720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloma and DNA damage.
    Tonon G
    Blood; 2024 Feb; 143(6):488-495. PubMed ID: 37992215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysfunctional homologous recombination mediates genomic instability and progression in myeloma.
    Shammas MA; Shmookler Reis RJ; Koley H; Batchu RB; Li C; Munshi NC
    Blood; 2009 Mar; 113(10):2290-7. PubMed ID: 19050310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microsatellite instability is a common finding in multiple myeloma.
    Timurağaoğlu A; Demircin S; Dizlek S; Alanoğlu G; Kiriş E
    Clin Lymphoma Myeloma; 2009 Oct; 9(5):371-4. PubMed ID: 19858056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic Aberrations in Multiple Myeloma.
    Manier S; Salem K; Glavey SV; Roccaro AM; Ghobrial IM
    Cancer Treat Res; 2016; 169():23-34. PubMed ID: 27696256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular profiling of multiple myeloma: from gene expression analysis to next-generation sequencing.
    Agnelli L; Tassone P; Neri A
    Expert Opin Biol Ther; 2013 Jun; 13 Suppl 1():S55-68. PubMed ID: 23614397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic Lethal Approaches Exploiting DNA Damage in Aggressive Myeloma.
    Cottini F; Hideshima T; Suzuki R; Tai YT; Bianchini G; Richardson PG; Anderson KC; Tonon G
    Cancer Discov; 2015 Sep; 5(9):972-87. PubMed ID: 26080835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloid transformation of plasma cell myeloma: molecular evidence of clonal evolution revealed by next generation sequencing.
    Gralewski JH; Post GR; van Rhee F; Yuan Y
    Diagn Pathol; 2018 Feb; 13(1):15. PubMed ID: 29463311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploiting MYC-induced PARPness to target genomic instability in multiple myeloma.
    Caracciolo D; Scionti F; Juli G; Altomare E; Golino G; Todoerti K; Grillone K; Riillo C; Arbitrio M; Iannone M; Morelli E; Amodio N; Di Martino MT; Rossi M; Neri A; Tagliaferri P; Tassone P
    Haematologica; 2021 Jan; 106(1):185-195. PubMed ID: 32079692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilizing next-generation sequencing in the management of multiple myeloma.
    Lionetti M; Neri A
    Expert Rev Mol Diagn; 2017 Jul; 17(7):653-663. PubMed ID: 28524737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic instability and proliferation/survival pathways in RB1-deficient malignancies.
    Pappas L; Xu XL; Abramson DH; Jhanwar SC
    Adv Biol Regul; 2017 May; 64():20-32. PubMed ID: 28242412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.